Brennan PJ, Brigl M, Brenner MB
Tighter oversight of manufacturers pricing policies and the competitive environment Its unseemly (polite word choice) that the CEO of Lilly, Dave Ricks, is able to rake in total compensation of $114 million in 2024 while at the same time acknowledging that the price his company charges for Zepbound is too high. Unseemly, because his payday was fueled by Lilly making more than $10 billion in profit from GLP-1s in 2024 alone
A structured medical weight loss program can assist by targeting the biological factors that regulate hunger, fullness, and how your body stores energy
this helps keep blood sugar in balance GLP-1 drugs work by mimicking the action of the GLP-1 hormone your body produces naturally
Up to 20% of women retain 9 pounds or more one year after giving birthand for many, that number doesnt budge
Noom Med didnt just help her shed poundsit helped her regain control over her body, energy, and long-term health